OP02.04: sFlt‐1 is an independent predictor of adverse outcomes in women with confirmed SARS‐CoV‐2 infection and hypertensive disorders of pregnancy.

Autor: Torres‐Torres, J., Hernández‐Pacheco, J., Espino‐y‐Sosa, S., Martinez‐Portilla, R.J., Mateu‐Rogell, P., Estrada‐Gutierrez, G., Solis‐Paredes, J., Rojas, L., Escobedo‐Segura, K.
Zdroj: Ultrasound in Obstetrics & Gynecology; Sep2022 Supplement S1, Vol. 60, p51-51, 1p
Abstrakt: The predictive model according to AIC and BIC criterion comprised sFlt-1 MoM (OR 5.13; p < 0.001), HDP (OR 32.76; p < 0.001), the interaction between sFlt-1 MoM/HDP (OR 0.28; p = 0.006), and MAP (OR 0.96; p = 0.030). To evaluate the association of sFlt-1 as a predictor of adverse outcome among women with hypertensive disorders of pregnancy (HDP) and SARS-CoV-2 infection. OP02.04: sFlt-1 is an independent predictor of adverse outcomes in women with confirmed SARS-CoV-2 infection and hypertensive disorders of pregnancy. [Extracted from the article]
Databáze: Complementary Index